US20210274818A1 - Methods for lowering gluten content using fungal cultures - Google Patents

Methods for lowering gluten content using fungal cultures Download PDF

Info

Publication number
US20210274818A1
US20210274818A1 US17/233,656 US202117233656A US2021274818A1 US 20210274818 A1 US20210274818 A1 US 20210274818A1 US 202117233656 A US202117233656 A US 202117233656A US 2021274818 A1 US2021274818 A1 US 2021274818A1
Authority
US
United States
Prior art keywords
gluten
prepared
containing grain
grain
fungal component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US17/233,656
Inventor
James Patrick Langan
Brooks John Kelly
Huntington DAVIS
Alan D. Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mycotechnology Inc
Original Assignee
Mycotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycotechnology Inc filed Critical Mycotechnology Inc
Priority to US17/233,656 priority Critical patent/US20210274818A1/en
Assigned to Mycotechnology, Inc. reassignment Mycotechnology, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DAVIS, Huntington, HAHN, Alan D., KELLY, BROOKS JOHN, LANGAN, JAMES PATRICK
Publication of US20210274818A1 publication Critical patent/US20210274818A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/104Fermentation of farinaceous cereal or cereal material; Addition of enzymes or microorganisms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/30Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/346Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of vegetable proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10Cereal-derived products
    • A23L7/197Treatment of whole grains not provided for in groups A23L7/117 - A23L7/196

Definitions

  • the present invention utilizes mycological methods to hydrolyze prolamin, glutelin and prolamin/glutelin complexes in grain.
  • the use of mycotechnological methods for the production of human and animal grade material is discussed as is the specific sequence of actions needed taken in order to successfully accomplish the manifestation of extensively hydrolyzed prolamin and glutelin in grain.
  • Celiac disease is an autoimmune disorder that inhibits the physiology and degrades the tissue of the small intestine due to the presence of serotypical HLA-DQ2 receptors that recognize deaminated gluten/glutaminase complexes as antigenic.
  • a gluten-free diet is the only medically accepted treatment. The disease affects an estimated 1% of adults worldwide and appears to be on the rise epidemiologically but because of the rare occurrence of symptoms it is believed that only 5-10% of cases are diagnosed. Tolerable gluten doses varies among people with celiac disease. Although there is no evidence to suggest a single definitive threshold a daily gluten intake of less than 10 mg is unlikely to cause significant histological issues.
  • a gluten-free diet is generally recommended to those with celiac disease.
  • Gluten-free is defined as 20 ppm (20 mg/kg) or less. It classification of gluten-free food includes food that has become gluten-free through “special processing”.
  • the present invention provides a method for the preparation of a gluten-containing grain having lowered levels of gluten.
  • the method includes providing a prepared gluten-containing grain.
  • the prepared gluten-containing grain may then be inoculated with a prepared fungal component and is incubated.
  • the prepared fungal component myceliates the prepared gluten-containing grain during incubation and hydrolyzes gluten in the gluten-containing grain.
  • the present invention also includes a gluten-containing grain having lowered levels of gluten, which has been prepared by the methods of the invention.
  • the method further includes drying and/or pasteurizing the grain having lowered levels of gluten after performing the steps of the method.
  • the method also may further comprise hydrating the gluten-containing grain with water prior to or following the sterilization step (with sterile water if hydrated post-sterilization), optionally with about 50% v/m water to grain and preferably with RO water.
  • the moisture content of the grain can be calibrated to any moisture content during myceliation if the mass and initial moisture content of the grain are known and the final moisture content and inoculant volume have been decided upon according to the following equation:
  • the gluten content of the substrate is brought to less than 20 mg/kg. In some embodiments the gluten content is brought to less than 10 mg/kg as, without being bound by theory, mycelium will eventually 100% consume bioavailable substrate, leading one to believe that material with 0 mg/kg gluten is possible due to the methods of the present invention.
  • the prepared fungal component is a submerged fungal liquid tissue culture and the incubation step comprises culturing the submerged fungal liquid tissue culture with the prepared gluten-containing grain for optionally between two and twenty-two days.
  • the submerged fungal liquid tissue culture is grown in a media comprising organic food powders and in another embodiment in human food-grade media and in another embodiment in animal-feed grade media.
  • Gluten as defined herein, is generally used to refer to a prolamin/glutelin complex aggregate.
  • the term ‘gluten’ henceforth refers to any prolamin, glutelin or prolamin/glutelin aggregate including the specific gliadin/glutenin aggregate known as gluten.
  • Prolamin and glutelin are generally understood to be precursors of gluten in food products.
  • Gluten is understood to be an aggregate of these two precursor proteins, formed and held together by disulfide bridges upon soaking and kneading. Gluten thus falls under the compound designation ‘prolamin/glutelin aggregate’.
  • Prolamin includes gliadin from wheat, hordein from barley, secalin from rye, avenin from oats, and zein from corn.
  • Glutelin in wheat flour includes glutenin.
  • Gluten can be measured by at least one of prolamin, glutenin, or prolamin/glutelin aggregate analysis, and in some embodiments, measured with ELISAs.
  • the prepared fungal component may include a species/strain from one or more of the following: Hericium erinaceus, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Trametes versicolor, Lentinula edodes, Armillariella mellea, Tricholoma matsutake, Flammulina velutipes, Volvariella volvacea, Agaricus campestris, Agaricus blazei, Grifola frondosa, Pholiota nameko, Agrocybe cylindracea, Boletus ornatipes, Ganoderma lucidum, Ganoderma applanatum, Hypsizygus marmoreus, Morchella angusticeps, Morchella esculenta, Morchella hortensis, Phellinus linteus, Auricularia auricula, Tre
  • the strain is from Morchella esculenta .
  • the strain is from Tricholoma matsutake .
  • the microorganism is any genetically modified organism mutated to secrete the proteolytic ‘glutenase’ or class of enzymes thereof that hydrolyze gluten according to the means of the present invention. Biochemical methods using this enzyme/enzymes may be possible though the mycological ability to penetrate crystalline solids may be an enabling aspect of the present invention that could render biochemical treatments of grain inefficacious.
  • the methods of the present invention can also lead to the increase of crude nitrogen in grain having reduced gluten compared to the starting material.
  • Such increases may be at least 5%, at least 10%, at least 15%, at least 20% and at least and or more than 50% increase in crude nitrogen.
  • the present invention also includes a gluten-containing grain having reduced levels of gluten prepared by the methods of the invention.
  • the present invention provides a method for the preparation of a gluten-containing grain having reduced levels of gluten.
  • the method includes providing a prepared gluten-containing grain.
  • the prepared gluten-containing grain is then inoculated with a prepared fungal component and allowed to incubate.
  • the prepared fungal component myceliates the gluten-containing grain during incubation, hydrolyzing gluten in the gluten-containing grain with a protease or proteases that will, as previously mentioned, likely be coined glutenase upon isolation and characterization of the protein(s).
  • prepared gluten-containing grain which includes the step of providing a gluten-containing grain or combinations thereof.
  • Gluten-containing grain refers to Triticum spp., Hordeum spp., Secale spp., Zea spp., Sorghum spp., and Avena spp.
  • the hard wheats have the highest gluten content and are used for making bread, rolls, and all-purpose flour.
  • the soft wheats are used for making flat bread, cakes, pastries, crackers, muffins, and biscuits.
  • the gluten-containing grain can be used after threshing as wheat heads or wheat berries.
  • the barley heads may be used after threshing.
  • Corn may be used while still attached to the ear, as it is taken off the ear or as cracked corn.
  • the gluten-containing grain is not dried prior to being used in the processes of the instant invention. In other embodiments the grain is dried.
  • the dried gluten-containing grain is prepared by a step of hydrating the gluten-containing grain. Hydration is particularly useful where the gluten-containing grain has been dried. Hydration ensures that the gluten-containing grain has optimal moisture content for the culturing process. Hydration may be accomplished by a number of methods known in the art. In one embodiment, the water is added to the grain directly before sterilization.
  • the hydration may be accomplished by an aqueous medium.
  • the aqueous medium includes water and, optionally, additional excipients.
  • Water may be distilled, filtered, ozonated or mineralized, or can be tap water.
  • Other excipients can be added to the water, such as buffers to maintain a certain pH, sodium chloride, citric acid, ascorbic acid etc.
  • the pH may be neutral or adjusted.
  • the temperature of the aqueous medium may be room temperature, or elevated in temperature to accelerate the hydration process.
  • Hydration may be accomplished by allowing the gluten-containing grain to soak in the aqueous medium for any appropriate length of time, ranging from a few seconds or less to overnight.
  • the hydration step may be less than a second, at least five seconds, at least ten seconds, at least thirty seconds, at least a minute, at least five minutes, at least ten minutes, at least twenty minutes, at least thirty minutes, at least forty minutes, at least fifty minutes, at least an hour, at least an hour and a half, or at least two hours.
  • the time for the hydration step should be selected in view of the fact that the gluten-containing grain is not sterile and soaking for too long of a time may encourage contamination.
  • the gluten-containing grain may be hydrated at any temperature that allows for effective hydration; in one embodiment the temperature of the aqueous component is room temperature. Hydration temperature should be selected in view of the fact that at high temperatures desirable flavor components may be altered.
  • Hydration may be performed under normal atmospheric pressure or may be performed under increased pressures to accelerate the hydration process, such as between 1 atmospheric pressure and 2 atmospheric pressures, for example, at 1.5 atmospheres.
  • the methods of the present invention further comprise a method of heat treatment such as pasteurizing and/or sterilizing the gluten-containing grain.
  • the gluten-containing grain is sterilized to provide prepared gluten-containing grain.
  • This step may be accomplished by any method known in the art. For example, this step may performed under atmospheric pressure or under increased pressure. This step may also be referred to as “pre-processing”. This step is performed to decrease the viability of undesirable microbial contaminate from growing on the gluten-containing grain.
  • gluten-containing grain may be subjected to dry heat treatment at atmospheric pressure at 145-190° F. for 30-90 minutes, and alternatively at 140-212° F. for 20-100 minutes.
  • Sterilization of the gluten-containing grain may be performed by methods known in the art.
  • Gluten-containing grain may for example be sterilized by heating under pressure at 15 lb/in 2 gauge at 121-122° C. for 20-180 minutes, such as 90 minutes.
  • suitable pasteurization conditions are 108-109° C. at 5 lb/in 2 , 115-116° C. at 10 lb/in 2 , for 20-90 minutes.
  • the steam is superheated to 250-255° F.
  • the pressures may vary from 5-25 lb/in 2 and are mostly dependent on altitude.
  • Gluten-containing grain may be sterilized in a container.
  • the container may optionally be the same container as the container used for hydration step.
  • the container may be optionally a sealed food-grade fermenter and the gluten-containing grain may be sterilized by the application of heat to the exterior (the fermentor's jacket) and interior of the container while being agitated.
  • the heat is provided by applying steam to the exterior of the container for a sufficient period of time to allow for sterilization of the contents.
  • Suitable containers include containers known in the art for mushroom cultivation.
  • the containers optionally have a section for exchanging air or gases but do not allow passage of any other component.
  • Such sections are known in the art and include filter strips.
  • the container is a drum, for example, a properly outfitted 55 gallon drum.
  • the container is a polypropylene bag with breather patch.
  • the containers of the instant invention can be glass, stainless steel or temperature-resistant high density polyethylene or polypropylene bags. Fermenters and bioreactors can also be used as containers of the instant invention. In some embodiments, the containers have a means for gas exchange that precludes passage of contaminants, such as filter zones or valves.
  • the container is a bag, for example an autoclavable, polypropylene bag with filter strips/patch, an autoclavable, high density polyethylene bag with filter zones or a gamma-irradiated polyethylene bag with filter zones.
  • the size of the bags to be used can be chosen according to the volume of gluten-containing grain to be treated by the methods of the present invention.
  • the fungal component to use with the present invention can be a strain from the Basidiomycetes or Ascomycetes, including the species: Hericium erinaceus, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Trametes versicolor, Lentinula edodes, Armillariella mellea, Boletus edulis, Tricholoma matsutake, Flammulina velufipes, Volvariella volvacea, Agaricus campestris, Agaricus blazei, Grifola frondosa, Pholiota nameko, Agrocybe cylindracea, Boletus ornatipes, Ganoderma lucidum, Ganoderma applanatum, Hypsizygus marmoreus, Morchella angusticeps, Morchella esculenta, Morchella hortens
  • Fungal components useful in the present invention may be prepared by methods as described herein.
  • a pure strain of fungus is used.
  • the pure strain of fungus is effectively able to grow on and/or myceliate the prepared gluten-containing grain to prepare the reduced gluten grain.
  • Any strain of fungus identified herein which is capable of effectively growing on and/or myceliating prepared gluten-containing grain can be used for the methods of the present invention given they have the ability to hydrolyze gluten. Two strains are discussed herein that have such ability.
  • the methods of the invention have as an optional additional step, a method of selecting a fungal component having an enhanced and/or increased ability to grow on, metabolize or otherwise utilize and/or modify gluten and/or remove gluten from the gluten-containing grain.
  • This method comprises screening a number of strains of a desired fungal species to select for a suitable fungal component which exhibits the enhanced and/or increased ability to grow on, metabolize, scavenge, or otherwise utilize and/or modify gluten-containing grain and/or hydrolyze gluten, and using this selected strain(s) in the methods of the invention.
  • a pure strain of any commercially available M. esculenta is used as the fungal component. While all strains of M. esculenta are effective for the present invention it was surprisingly found that some selected strains have the enhanced abilities useful for the present invention as described herein.
  • One such strain useful for the fungal component of the present invention is M. esculenta WC833 commercially available from Pennsylvania State University (The Pennsylvania State University Mushroom Culture Collection, available from the College of Agriculture Sciences, Department of Plant Pathology and Environmental Microbiology, 117 Buckhout Laboratory, The Pennsylvania State University, University Park, Pa., USA 16802), which demonstrated a heightened ability to grow on hard red winter wheat.
  • Another strain useful for the present invention is a wild-type T. matsutake collected from the Rocky Mountains in the hills just around Nederland, Colo.
  • a filtrate of undefined vegetable (of any type but ideally organic) aqueous extract, such as malt, potato, carrot or a combination thereof is used as growth media.
  • Aqueous potato mixture can be prepared by softening 1-300 g of potato mass in boiling or pressurized water, mashing the potatoes and collecting the filtrate through 1-3 filtrations.
  • fruit juice with no added sugars can also be added.
  • the medium comprises 0.1-10% by weight of malt extract, 0.1-10% by weight of glucose, and 20-80% by weight of water.
  • agar media can be prepared from a media of 15-60 g/L agar with 3-20 g/L organic potato starch powder, 0.3-12 g/L organic carrot powder and 10-200 mL/L organic mango puree in RO filtered water. Any combination of these ingredients may be used. Additional media can include nutritional yeast, brown rice syrup, blackstrap molasses and salts such as diammonium phosphate and ammonium sulfate, all used as is generally done in the art. These solutions are combined and autoclaved. Liquid media is made by the same recipe except agar is omitted.
  • the media can be sterilized by any method known in the art. Once the media has cooled post-sterilization it is poured into Petri plates and fungal cultures are propagated from plate to plate in good and clean technical operation as known in the art. Slants for test tubes, liquid flasks and glycerol stocks may be prepared by this method. Petri plates can be inoculated with floating and submerged liquid tissue culture and with myceliated grain.
  • the fungal component for inoculation into gluten-containing grain can be prepared by submerged liquid tissue culture using the liquid media as defined herein and agitated on a shaker table.
  • the agitation rate is 50-240 RPM, or 85-95 RPM, and incubated for 1-90 days.
  • the temperature of incubation is 87-89 ° F.
  • the fungal component is trained and/or adapted and/or maintained in its ability to efficiently grow on, metabolize or otherwise utilize and/or modify gluten.
  • the methods of the invention have as an optional additional step, a method of preparing a trained and/or adapted and/or maintained fungal component comprising a fungal component having an enhanced and/or increased ability to grow on, metabolize or otherwise utilize and/or modify gluten and/or remove gluten from the gluten-containing grain.
  • the methods of the invention further comprise use of any of the trained, adapted and/or maintained fungal component(s) as described herein, in the methods of the instant invention.
  • methods for preparing the fungal component to inoculate the prepared gluten-containing grain include scaling up a fungal component as defined herein into a large volume bioreactor culture for the inoculation of numerous bags of prepared gluten-containing grain (20-1,000 bags) or for the inoculation of fermenter(s) with large volumes of inoculant (e.g. 10-500 L of inoculant per fermenter).
  • a fungal component which is readied for inoculation of the prepared gluten-containing grain is called a “prepared fungal component”.
  • the prepared fungal component is in solid culture. In another embodiment the prepared fungal component is in liquid culture. In another embodiment the prepared fungal component is a mixture of solid and liquid culture.
  • Liquid culture can be accomplished by any means known in the art and includes use of stationary culture and/or a bioreactor. For example, when using a bioreactor to prepare the fungal component, the bioreactor can be prepared by diluting undefined liquid media up to 1000 ⁇ with filtered water.
  • the jacket of the bioreactor may be steamed in one embodiment to sterilize the media, or alternatively, the media can be sterilized by way of injecting steam into the vessel. In another embodiment both jacket and chamber are steamed.
  • the fermenter is sterilized empty and filled with filter sterilized water and with a sterilized media concentrate, either sterilized in situ and pumped into the fermenter through a sterile line, filter sterilized or sterilized in small batches and pumped into the fermentor. Pasteurization is possible for any or all of these procedures.
  • the media to use in preparation of a fungal component for use to inoculate the prepared gluten-containing grain may be any suitable media known in the art so long as it is human grade (or animal-feed grade depending on the intention of the myceliation) or may be made by the methods disclosed herein.
  • the media may further comprise trace elements and organic substances such as water, nucleic acids, nitrogen content, vitamins and minerals.
  • the media may be diluted up to 1000 ⁇ with filtered water.
  • Dilution can be 1 ⁇ , about 2 ⁇ , about 3 ⁇ , about 4 ⁇ , about 5 ⁇ , about 6 ⁇ , about 7 ⁇ , about 8 ⁇ , about 9 ⁇ , about 10 ⁇ , about 15 ⁇ , about 20 ⁇ , about 25 ⁇ , about 30 ⁇ , about 35 ⁇ , about 40 ⁇ , about 45 ⁇ , about 50 ⁇ , about 55 ⁇ , about 60 ⁇ , about 65 ⁇ , about 70 ⁇ , about 80 ⁇ , about 90 ⁇ , about 100 ⁇ , about 150 ⁇ , about 200 ⁇ , about 250 ⁇ , about 300 ⁇ , about 350 ⁇ , about 400 ⁇ , about 450 ⁇ , about 500 ⁇ , about 550 ⁇ , about 600 ⁇ , about 650 ⁇ , about 700 ⁇ , about 750 ⁇ , about 800 ⁇ , about 850 ⁇ , about 900 ⁇ , about 950 ⁇ or about 1000 ⁇ .
  • the dilution is about 5 ⁇ to about 100 ⁇ .
  • the dilution is about 10 ⁇ .
  • media may be pumped from another reactor through a sterilized line with an inline pump or by creating positive pressure by sparging air into the reactor with an air compressor system that runs the air through inline 0.2/0.5 ⁇ m capsule filters, or equivalent stainless steel cartridge filters, and then through a check valve with a specific cracking pressure, for example, 2-3 psi. Pressure can also be held with a back-pressure regulator. Additionally, pressure can be regulated upstream with a pressure regulator. A slightly pressurized fermenter (1-3 psi) may be opened and have culture poured into it in a clean environment. This procedure is dangerous and should only be executed by one of skill in the art.
  • Methods to inoculate the bioreactor to prepare the fungal component include inoculating the bioreactor with an excised colonized section of Petri plate and/or a sample of myceliated agriculture using sterile procedure, or by pouring a floating or submerged liquid tissue culture into the bioreactor through the nozzle or through a pump.
  • the fungal component optionally may be agitated during culturing by methods known in the art.
  • the agitation may be accomplished by a combination of sparged air and a motorized paddle which allows both a turbulent environment and shear mechanical force.
  • the inventors without limitation, have found that the combination is superior to running either method individually, as sparged air creates the most turbulence at the top half of the culture, while affecting the bottom less, which can be kept agitated by a motorized paddle, while the paddle does not have to run at such a high RPM as normally used in the art.
  • More sophisticated setups are known and can be enacted to agitate a bioreactor with liquid culture. Solid state fermenter work has many options known in the art, the most ideal being rotating buckets or agars to evenly and gently agitate grain.
  • Liquid state fermentation agitation and swirling techniques are known in the art and include mechanical shearing using magnetic stir bars, stainless steel impellers, injection of sterile high pressure ambient air, injection at high-pressure of sterile media, and or the use of shaker tables.
  • the fungal component can be grown until ready for inoculation of the prepared gluten-containing grain as determined by one of skill in the art and is most easily monitored with pH.
  • the procedure generally includes a rise in pH.
  • the fungal component can be grown for 72 hours prior to use in inoculating the gluten-containing grain. Determination of whether the fungal cultures comprising the fungal component are suitable for inoculation of the prepared gluten-containing grain can be determined by one of skill in the art.
  • the fungal culture when in liquid media, is suitable for inoculation while in log phase, either early or late. Senescing cultures and cultures in secondary phases with lower amounts of mycelia/mL can be used but are not preferred.
  • the prepared fungal component optionally appears well grown through in the media, with visible mycelia growing through every mL visible by microscope and unassisted vision.
  • the prepared gluten-containing grain is inoculated with the prepared fungal component in a manner so as not to contaminate the culture.
  • the prepared fungal component to be used can be any fungal component as defined in the instant invention.
  • the inoculation of the prepared fungal component onto the prepared gluten-containing grain can be carried out by any method known in the art. This step may be variously referred to as the culturing step, the fermentation step, the incubation step, and/or the myceliation step.
  • the myceliation may take place in a container as described herein.
  • the myceliation takes place in a 55 gallon drum as described herein.
  • the 55 gallon drums has a lid containing two ports, and one port can be used as an inoculation port, while the other can be used to sparge in filtered air to the bottom of the culture, and simultaneously serve as a vent.
  • the inoculation port is a quick disconnect socket, which is attached to a quick disconnect plug at the end of a harvesting line during inoculation.
  • prepared gluten-containing grain in a plurality of drums can be myceliated in one cycle via a sterilized manifold connected to bioreactor harvesting line, with the included infrastructure to target any drum in singular or all together at once.
  • a system for volumetrically consistent dispensing of inoculant per culture is used.
  • the culture may be pneumatically injected into a container comprising the prepared gluten-containing grain. Moisture may optionally be injected into bags to optimize mycelial growth.
  • the prepared gluten-containing grain is inoculated by pouring the culture into the container holding the sterilized gluten-containing grain either manually or through a valve built into the fermenter or bioreactor, the line between the culture containing device and the fermenter/bioreactor being sterilized and cooled, from any variety of liquid tissue culture.
  • the prepared gluten-containing grain is cooled to a temperature of between 80-100° F. post-sterilization prior to inoculation with the prepared fungal component. Cooling may be accomplished by refrigeration, by running a cooling agent through the fermenter jacket (if using this embodiment) or naturally at room temperature.
  • the step of myceliating the prepared gluten-containing grain can take place for between 1-90 days, and in one embodiment for about 21 days, and at any temperature that enables myelical activity, for example, at 87-89° F.
  • the culture is incubated at room temperature. In another embodiment it is incubated at 65° F. The culture is optionally incubated at 50-90° F.
  • Relative humidity of the solid-state myceliation step is between 20% and 90% and in some embodiments about 75%.
  • Determination of when to harvest the myceliated gluten-containing grain may be determined by a number of methods.
  • Harvesting is generally performed with a timing to optimize the taste profile and/or gluten hydrolysis of the myceliated gluten-containing grain according to the taste profile or gluten level desired.
  • the scent profile of the myceliation culture can be used by the trained person to determine when the culture is ready.
  • Determination of the appearance of the culture may also be done by the trained person.
  • Analytical methods of analysis including high performance liquid chromatography (HPLC), PAGE, ELISA etc. may be employed to carry out measurement of gluten or other biomolecules, in order to determine the optimum composition and cultivation conditions and the appropriate time(s) for harvesting the myceliated grain.
  • the step of culturing or myceliation may also cause reduction and/or removal of gluten as described herein.
  • determination of the extent of the removal of gluten can be by quantitation, e.g., the chemical composition may be measured by assay methods as are known in the art for gluten measurement.
  • up to 5% of one or more the proteins comprising gluten is removed; in other embodiments, up to 10%, up to 15%, up to 20%, up to 25%, up to 30%, up to 35%, up to 40%, up to 45%, up to 50%, up to 55%, up to 60%, up to 65%, up to 70%, up to 75%, up to 80%, up to 85%, up to 90%, up to 95%, up to 99%, or up to 99.9% of one or more of gluten is removed in the processes of the instant invention.
  • gluten is quantitatively removed and is less than about 20 ppm.
  • the invention also relates to myceliated gluten-containing grain having reduced levels of gluten as described herein.
  • the culturing or myceliation processes of the instant invention provide a myceliated gluten-containing grain with added flavor and/or health promoting components.
  • the myceliated gluten-containing grain may contain exogenously added anti-tumor and immunomodulatory health promoting components such as (1->3)(1->6) ⁇ -glucan from the fungi.
  • Fungi are metabolically similar to animals but structurally similar to plants in that they possess a rigid cell wall largely comprising long polysaccharides ( ⁇ -glucan and chitin) joined by somewhat difficult to digest beta (( ⁇ -) linkages and to a smaller extent more easily digestible alpha ( ⁇ -) linkages in conjunction with membrane-bound proteins.
  • plant cell walls (such as gluten-containing grains) are made of cellulose polysaccharides whose (1->4) ( ⁇ -glycosidic bonds are impossible for humans to digest but are digestible by fungi.
  • Fungi cell walls are primarily composed of (1->3) glycosidic linkages, with (1->6) linked side chains, and therefore they may be broken down by minimal processing using water, heat and mechanical treatment, into smaller, more easily digestible, immunologically-active polysaccharides of variable microparticulate size called and related glycoconjugates.
  • the immune response to ⁇ -glucan is dependent upon ⁇ - or ⁇ -glucan structure, which has primary, secondary, and chiral tertiary structures, explaining the differences in immune response to each fungi's unique ⁇ - and/or ⁇ -glucan profile.
  • Myceliated gluten-containing grain thus has added health promoting components including the molecules described above.
  • Other health promoting components present in the myceliated gluten-containing grain may be components that have various properties such as immunomodulating, anti-aging, aphrodisiac, anti-tumour, anti-viral, anti-bacterial and/or anti-fungal properties and include compounds such as ⁇ - and ⁇ -glucans, glycoproteins, proteins, ergosterols, sterols, triterpenes, and fatty acids, glucomannan, riboglucan, sterpuric acid, mannitol, ribitol, nucleic acid content, etc. These molecules are reputed to be immune boosting and modulating, specifically modulating from a Th2 to Th1 immune response.
  • the myceliated gluten-containing grain is optionally dried. Drying can be accomplished by means known in the art for drying gluten-containing grain. For example, myceliated gluten-containing grain may be spread on a dry surface to dry. In one embodiment, the myceliated gluten-containing grain is dried down to an approximately 10-13% moisture content.
  • the dried or undried myceliated gluten-containing grain can be pasteurized or sterilized by methods known in the art, which provides for deactivating the fungus.
  • the myceliated gluten-containing grain may then be used as desired.
  • the grain can then be used as per usual and either milled or not. Because more than one strain of filamentous fungus has been discovered to hydrolyze gluten in the solid-state it is likely that more exist.
  • Mycelial samples were grown in a gentle, ambient sterile airflow for 0.5-4 weeks, then excised from Petri plates and subsequently used for inoculation into liquid-state myceliation employing a similar undefined fruit and vegetable-based media (but with no agar) using ambient air in 1 qt-1 gal glass jars. Some samples were grown in agitated and some were grown in unagitated cultures in ambient air in stainless steel fermenters.
  • the unagitated liquid state fermentation formed a floating mass of hyphae which exhibited continuous growth at interface of liquid and air.
  • the mycelium of agitated and/or swirling cultures grew very quickly as hyphal spheres which, being hydrated, remained submerged and had the appearance of small diameter gelatinous beads. Hydrated hyphal spheres collapsed upon desiccation, wherein they were used for inoculating petri-plates for strain propagation and quality control.
  • Sphere diameter in liquid-state myceliation was found to be inversely proportional to agitation intensity and volume. Hyphal shear became more efficient at higher agitation and swirling intensity and once sheared hyphae formed new spheres of smallest possible diameter, growing in size until they sheared again. When employed in continuous liquid-state myceliation there existed a constant ratio of sphere diameters, and therefore a constant supply of spheres and hyphal strands adopting spherical morphologies on the order of microns were produced.
  • Stationary liquid cultures (growth period of 0.1-4 weeks) formed a floating mass of hyphae, which were gently blended with a sharp, sterile cutting device prior to being used for inoculation.
  • gentle blending was achieved by mixing or low homogenization in a commercial blender in short bursts at slow speeds. Aliquots of blended liquid-state culture were used to inoculate substrate.
  • Agar media was prepared with 15-60 g/L agar and 3-22 g/L organic potato starch powder, 0.3-12 g/L organic carrot powder, and 40 mL/L organic mango puree in RO water.
  • the 1.5 L media was then subjected to a 1.5 hour liquid sterilization cycle and cooled in a clean space for 1-1.5 hours and then poured into 120 Petri plates which cooled for 12 hours.
  • the Petri plates were inoculated and cultured for 7-14 days. Upon which time they were sterilely propagated into 4 L Erlenmeyer flasks containing 1.5 L of sterilized and cooled media prepared as above but without the mango puree and agar. This culture was shaken at 60 RPM with a 1.5′′ swing radius at room temperature for 1-14 days. This culture was used to inoculate organic hard red winter wheat which was prepared as described below.
  • the bags were loaded into an autoclave and subjected to a 1.5 hr liquid sterilization cycle. Once sterilized the bags were cooled in a clean space for 12 hours. Each bag was then inoculated with 170 mL of a submerged liquid tissue culture of M. esculenta which had been cultured for 8 days and then sealed with a bag sealer.
  • the bags myceliated in a clean space for 21 days, upon which time there was resplendent growth of mycelial hyphae throughout the wheat.
  • the bags' content were dried indoors for three days on parchment paper in a laminar air flow.
  • duplicate samples of myceliated and autoclaved grain were sent to a third-party laboratory to detect the gluten and glutenin fractions of gluten using an ELISA method (Elisa Technologies, Gainesville, Fla., Aller-Tek® Gluten ELISA test kit).
  • the autoclaved control samples were stored at ⁇ 20 ° C. for the duration of the myceliation.
  • the third-party report concluded an average gluten content of 30 ppm while the control had a level too high to quantitate (the upper limit of quantitation was 80 ppm).
  • the estimated gluten content of the control based on the total protein content and the typical gluten precursor fraction of such wheat is 135,000-160,000 ppm, indicating a greater than 99.99% reduction in gluten content.
  • the myceliated gluten-containing grain was essentially aductile and did not knead.
  • the grain is dispensed into a food grade pressure vessel capable of agitation, and is sterilized. This is the most efficient way to sterilize and cool large volumes of grain.
  • the grain is inoculated in situ, with controlled humidity, sterile air supply and temperature. Once myceliation is deemed complete, a process that will take anywhere from 1-22 days if done properly (e.g. the culture is at peak vigor of the log phase, the grain serendipitously provides a desirable carbon/nitrogen ratio, contamination is kept at bay, humidity and temperature are controlled for, etc.), and even shorter with some strains.
  • the grain can then be pasteurized in this pressure vessel by methods known in the art, if so desired, and even dried therein.
  • the grain is considered ‘gluten-free’ by many of the world's regulatory authorities. Methods known in the art can easily produce a ‘gluten-free’ flour according to the FDA, and some embodiments of the invention will produce a grain with gluten content less than 20 ppm.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides a method for the preparation of a gluten-containing grain having lowered levels of gluten. The method includes providing a prepared gluten-containing grain which may be optionally sterilized or pasteurized. The prepared gluten-containing grain is then inoculated with a prepared fungal component and incubated. In one embodiment the prepared fungal component myceliates the prepared gluten-containing grain while incubated and during this process hydrolyzes gluten in the prepared gluten-containing grain. The present invention also includes a gluten-containing grain having lowered levels of gluten which has been prepared by the methods of the invention.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation application of U.S. application Ser. No. 15/551,894, filed Aug. 17, 2017, which is a U.S. National Phase application under 35 USC § 371 of International Patent Application No. PCT/US2016/019929, filed Feb. 26, 2016, which designates the United States, and claims priority to U.S. Provisional Application No. 62/121,483 filed Feb. 26, 2015, each of which are incorporated herein by reference in their entireties
  • TECHNICAL FIELD
  • The present invention utilizes mycological methods to hydrolyze prolamin, glutelin and prolamin/glutelin complexes in grain. The use of mycotechnological methods for the production of human and animal grade material is discussed as is the specific sequence of actions needed taken in order to successfully accomplish the manifestation of extensively hydrolyzed prolamin and glutelin in grain.
  • BACKGROUND
  • Celiac disease is an autoimmune disorder that inhibits the physiology and degrades the tissue of the small intestine due to the presence of serotypical HLA-DQ2 receptors that recognize deaminated gluten/glutaminase complexes as antigenic. A gluten-free diet is the only medically accepted treatment. The disease affects an estimated 1% of adults worldwide and appears to be on the rise epidemiologically but because of the rare occurrence of symptoms it is believed that only 5-10% of cases are diagnosed. Tolerable gluten doses varies among people with celiac disease. Although there is no evidence to suggest a single definitive threshold a daily gluten intake of less than 10 mg is unlikely to cause significant histological issues. A gluten-free diet is generally recommended to those with celiac disease.
  • Regulation of the gluten-free label varies by country. Most countries derive key provisions of their gluten-free labeling regulations from the Codex Alimentarius International Food Standards for labeling, which has a standard relating to the labeling of products as gluten-free. Gluten-free is defined as 20 ppm (20 mg/kg) or less. It classification of gluten-free food includes food that has become gluten-free through “special processing”.
  • The inventors have developed methods for myceliating agricultural substrates, see, e.g., PCT/US14/29989, filed Mar. 15, 2014, PCT/US14/29998, filed Mar. 15, 2014, U.S. 61/953,821, filed Mar. 15, 2014, U.S. 61/953,823, filed Mar. 15, 2014, U.S. 62/042,071, filed Aug. 26, 2014, all of which are incorporated by reference herein in their entireties.
  • A need remains in the art for gluten-containing products with reduced gluten levels and for methods of obtaining such products. There are no reports of higher order filamentous fungi hydrolyzing gluten as described herein and in view of art it is apparent that efficient digestion of gluten is difficult.
  • SUMMARY OF THE INVENTION
  • The present invention provides a method for the preparation of a gluten-containing grain having lowered levels of gluten. The method includes providing a prepared gluten-containing grain. The prepared gluten-containing grain may then be inoculated with a prepared fungal component and is incubated. In one embodiment the prepared fungal component myceliates the prepared gluten-containing grain during incubation and hydrolyzes gluten in the gluten-containing grain. The present invention also includes a gluten-containing grain having lowered levels of gluten, which has been prepared by the methods of the invention.
  • In one embodiment the method further includes drying and/or pasteurizing the grain having lowered levels of gluten after performing the steps of the method. The method also may further comprise hydrating the gluten-containing grain with water prior to or following the sterilization step (with sterile water if hydrated post-sterilization), optionally with about 50% v/m water to grain and preferably with RO water. In one embodiment the moisture content of the grain can be calibrated to any moisture content during myceliation if the mass and initial moisture content of the grain are known and the final moisture content and inoculant volume have been decided upon according to the following equation:
      • Let M=substrate mass (kg)
      • MCi=initial moisture content (% in decimal)
      • MCf=final moisture content (% in decimal)
      • I=inoculation volume (L)
      • H=hydration volume (L)
  • H = M ( M C f - M C i ) + I ( M C f - 1 ) ( 1 - M C f )
  • Many variations of this equation are possible depending on the formulator's perspective. It may be preferable to consider the bulk density of the substrate in order to control for headspace volume during myceliation. Such an equation using the variables from above and others listed below:
  • Let Vc=volume of container (L)
      • %s=percent of container filled with substrate (% as decimal)
      • BD=bulk density of pre-hydrated substrate (kg/L)
  • M = BD ( V c % s - 2 I ) 1 + B D ( M C f - M C i ) 1 - M C f H = B D ( V c % s - 2 I ) ( M C f - M C i ) ( 1 + B D ( M C f - M C i ) 1 - M C f ) ( 1 - M C f ) - I
  • Other embodiments of these equations are possible and are in large part used according to the perspective of the mycologist preparing the substrate. It is possible to develop such equations considering the percentage of inoculant volume to substrate mass, inoculant volume to substrate volume plus hydration volume etc., in order to precisely determine substrate moisture content during the myceliation step and control for conditions between cultures.
  • In some embodiments, greater than or equal to about 90%, 95%, 99%, 99.5%, or 99.99% of the gluten is removed by the methods of the invention. In some embodiments the gluten content of the substrate is brought to less than 20 mg/kg. In some embodiments the gluten content is brought to less than 10 mg/kg as, without being bound by theory, mycelium will eventually 100% consume bioavailable substrate, leading one to believe that material with 0 mg/kg gluten is possible due to the methods of the present invention.
  • In one embodiment, the prepared fungal component is a submerged fungal liquid tissue culture and the incubation step comprises culturing the submerged fungal liquid tissue culture with the prepared gluten-containing grain for optionally between two and twenty-two days. In one embodiment, the submerged fungal liquid tissue culture is grown in a media comprising organic food powders and in another embodiment in human food-grade media and in another embodiment in animal-feed grade media.
  • Gluten, as defined herein, is generally used to refer to a prolamin/glutelin complex aggregate. The term ‘gluten’ henceforth refers to any prolamin, glutelin or prolamin/glutelin aggregate including the specific gliadin/glutenin aggregate known as gluten. Prolamin and glutelin are generally understood to be precursors of gluten in food products. Gluten is understood to be an aggregate of these two precursor proteins, formed and held together by disulfide bridges upon soaking and kneading. Gluten thus falls under the compound designation ‘prolamin/glutelin aggregate’. Prolamin includes gliadin from wheat, hordein from barley, secalin from rye, avenin from oats, and zein from corn. Glutelin in wheat flour includes glutenin. Gluten can be measured by at least one of prolamin, glutenin, or prolamin/glutelin aggregate analysis, and in some embodiments, measured with ELISAs.
  • The prepared fungal component may include a species/strain from one or more of the following: Hericium erinaceus, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Trametes versicolor, Lentinula edodes, Armillariella mellea, Tricholoma matsutake, Flammulina velutipes, Volvariella volvacea, Agaricus campestris, Agaricus blazei, Grifola frondosa, Pholiota nameko, Agrocybe cylindracea, Boletus ornatipes, Ganoderma lucidum, Ganoderma applanatum, Hypsizygus marmoreus, Morchella angusticeps, Morchella esculenta, Morchella hortensis, Phellinus linteus, Auricularia auricula, Tremella fuciformis, Inonotus obliquus, Fomes fomentarius, Laetiporus sulfureus, Bridgeoporus nobillismus, Stropharia rugossannulata, edible Clitocybe spp., Cordyceps sinensis, Cordyceps militaris, Polyporus umbellatus, and combinations thereof. In some embodiments the strain is from Morchella esculenta. In another embodiment the strain is from Tricholoma matsutake. In another embodiment the microorganism is any genetically modified organism mutated to secrete the proteolytic ‘glutenase’ or class of enzymes thereof that hydrolyze gluten according to the means of the present invention. Biochemical methods using this enzyme/enzymes may be possible though the mycological ability to penetrate crystalline solids may be an enabling aspect of the present invention that could render biochemical treatments of grain inefficacious.
  • The methods of the present invention can also lead to the increase of crude nitrogen in grain having reduced gluten compared to the starting material. Such increases may be at least 5%, at least 10%, at least 15%, at least 20% and at least and or more than 50% increase in crude nitrogen.
  • The present invention also includes a gluten-containing grain having reduced levels of gluten prepared by the methods of the invention.
  • DETAILED DESCRIPTION OF THE INVENTION
  • In one embodiment the present invention provides a method for the preparation of a gluten-containing grain having reduced levels of gluten. The method includes providing a prepared gluten-containing grain. The prepared gluten-containing grain is then inoculated with a prepared fungal component and allowed to incubate. In one embodiment, the prepared fungal component myceliates the gluten-containing grain during incubation, hydrolyzing gluten in the gluten-containing grain with a protease or proteases that will, as previously mentioned, likely be coined glutenase upon isolation and characterization of the protein(s).
  • In one embodiment prepared gluten-containing grain is provided which includes the step of providing a gluten-containing grain or combinations thereof. Gluten-containing grain refers to Triticum spp., Hordeum spp., Secale spp., Zea spp., Sorghum spp., and Avena spp. There are six general wheat classifications: 1) hard red winter, 2) hard red spring, 3) soft red winter, 4) durum (hard), 5) Hard white and 6) soft white wheat though there are numerous species amongst these six. The hard wheats have the highest gluten content and are used for making bread, rolls, and all-purpose flour. The soft wheats are used for making flat bread, cakes, pastries, crackers, muffins, and biscuits.
  • For wheat, the gluten-containing grain can be used after threshing as wheat heads or wheat berries. For barley the barley heads may be used after threshing. Corn may be used while still attached to the ear, as it is taken off the ear or as cracked corn.
  • In some embodiments, the gluten-containing grain is not dried prior to being used in the processes of the instant invention. In other embodiments the grain is dried.
  • In some embodiments, the dried gluten-containing grain is prepared by a step of hydrating the gluten-containing grain. Hydration is particularly useful where the gluten-containing grain has been dried. Hydration ensures that the gluten-containing grain has optimal moisture content for the culturing process. Hydration may be accomplished by a number of methods known in the art. In one embodiment, the water is added to the grain directly before sterilization.
  • The hydration may be accomplished by an aqueous medium. The aqueous medium includes water and, optionally, additional excipients. Water may be distilled, filtered, ozonated or mineralized, or can be tap water. Other excipients can be added to the water, such as buffers to maintain a certain pH, sodium chloride, citric acid, ascorbic acid etc. The pH may be neutral or adjusted. The temperature of the aqueous medium may be room temperature, or elevated in temperature to accelerate the hydration process.
  • Hydration may be accomplished by allowing the gluten-containing grain to soak in the aqueous medium for any appropriate length of time, ranging from a few seconds or less to overnight. The hydration step may be less than a second, at least five seconds, at least ten seconds, at least thirty seconds, at least a minute, at least five minutes, at least ten minutes, at least twenty minutes, at least thirty minutes, at least forty minutes, at least fifty minutes, at least an hour, at least an hour and a half, or at least two hours. The time for the hydration step should be selected in view of the fact that the gluten-containing grain is not sterile and soaking for too long of a time may encourage contamination. Slightly longer soaking times (upwards of two hours), will shorten sterilization cycles, as most spores will have sprouted and will require less energy to kill. It is of primary importance that the water and mass of grain are not separated at any time post-hydration.
  • The gluten-containing grain may be hydrated at any temperature that allows for effective hydration; in one embodiment the temperature of the aqueous component is room temperature. Hydration temperature should be selected in view of the fact that at high temperatures desirable flavor components may be altered.
  • Hydration may be performed under normal atmospheric pressure or may be performed under increased pressures to accelerate the hydration process, such as between 1 atmospheric pressure and 2 atmospheric pressures, for example, at 1.5 atmospheres.
  • In one embodiment, about 50% v/m of water to the gluten-containing grain is added; however this proportion may be adjusted to optimize the myceliation processes of the instant invention according to the equations discussed in the summary of the invention.
  • The methods of the present invention further comprise a method of heat treatment such as pasteurizing and/or sterilizing the gluten-containing grain. In one embodiment, the gluten-containing grain is sterilized to provide prepared gluten-containing grain. This step may be accomplished by any method known in the art. For example, this step may performed under atmospheric pressure or under increased pressure. This step may also be referred to as “pre-processing”. This step is performed to decrease the viability of undesirable microbial contaminate from growing on the gluten-containing grain.
  • Methods for pasteurization and/or sterilization may be carried out as known in the art. As an example of pasteurization, gluten-containing grain may be subjected to dry heat treatment at atmospheric pressure at 145-190° F. for 30-90 minutes, and alternatively at 140-212° F. for 20-100 minutes.
  • Sterilization of the gluten-containing grain may be performed by methods known in the art. Gluten-containing grain may for example be sterilized by heating under pressure at 15 lb/in2 gauge at 121-122° C. for 20-180 minutes, such as 90 minutes. Examples of suitable pasteurization conditions are 108-109° C. at 5 lb/in2, 115-116° C. at 10 lb/in2, for 20-90 minutes. In another embodiment, the steam is superheated to 250-255° F. The pressures may vary from 5-25 lb/in2 and are mostly dependent on altitude. Gluten-containing grain may be sterilized in a container. The container may optionally be the same container as the container used for hydration step. The container may be optionally a sealed food-grade fermenter and the gluten-containing grain may be sterilized by the application of heat to the exterior (the fermentor's jacket) and interior of the container while being agitated. In one embodiment, the heat is provided by applying steam to the exterior of the container for a sufficient period of time to allow for sterilization of the contents.
  • Suitable containers include containers known in the art for mushroom cultivation. The containers optionally have a section for exchanging air or gases but do not allow passage of any other component. Such sections are known in the art and include filter strips. In one embodiment, the container is a drum, for example, a properly outfitted 55 gallon drum. In another embodiment the container is a polypropylene bag with breather patch.
  • In some embodiments, the containers of the instant invention can be glass, stainless steel or temperature-resistant high density polyethylene or polypropylene bags. Fermenters and bioreactors can also be used as containers of the instant invention. In some embodiments, the containers have a means for gas exchange that precludes passage of contaminants, such as filter zones or valves.
  • In one embodiment the container is a bag, for example an autoclavable, polypropylene bag with filter strips/patch, an autoclavable, high density polyethylene bag with filter zones or a gamma-irradiated polyethylene bag with filter zones.
  • The size of the bags to be used can be chosen according to the volume of gluten-containing grain to be treated by the methods of the present invention.
  • Fungal Component
  • The fungal component to use with the present invention can be a strain from the Basidiomycetes or Ascomycetes, including the species: Hericium erinaceus, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Trametes versicolor, Lentinula edodes, Armillariella mellea, Boletus edulis, Tricholoma matsutake, Flammulina velufipes, Volvariella volvacea, Agaricus campestris, Agaricus blazei, Grifola frondosa, Pholiota nameko, Agrocybe cylindracea, Boletus ornatipes, Ganoderma lucidum, Ganoderma applanatum, Hypsizygus marmoreus, Morchella angusticeps, Morchella esculenta, Morchella hortensis, Phellinus linteus, Auricularia auricula, Tremella fuciformis, Inonotus obliquus, Fomes fomentarius, Laetiporus sulfureus, Bridgeoporus nobillismus, Stropharia rugossannulata, edible Clitocybe spp., Cordyceps sinensis, Cordyceps militaris and Polyporus umbellatus. Combinations of the above fungi may also be used.
  • Fungal components useful in the present invention may be prepared by methods as described herein. For example, in one embodiment a pure strain of fungus is used. In some embodiments the pure strain of fungus is effectively able to grow on and/or myceliate the prepared gluten-containing grain to prepare the reduced gluten grain. Any strain of fungus identified herein which is capable of effectively growing on and/or myceliating prepared gluten-containing grain can be used for the methods of the present invention given they have the ability to hydrolyze gluten. Two strains are discussed herein that have such ability.
  • The methods of the invention have as an optional additional step, a method of selecting a fungal component having an enhanced and/or increased ability to grow on, metabolize or otherwise utilize and/or modify gluten and/or remove gluten from the gluten-containing grain. This method comprises screening a number of strains of a desired fungal species to select for a suitable fungal component which exhibits the enhanced and/or increased ability to grow on, metabolize, scavenge, or otherwise utilize and/or modify gluten-containing grain and/or hydrolyze gluten, and using this selected strain(s) in the methods of the invention.
  • In one embodiment a pure strain of any commercially available M. esculenta is used as the fungal component. While all strains of M. esculenta are effective for the present invention it was surprisingly found that some selected strains have the enhanced abilities useful for the present invention as described herein. One such strain useful for the fungal component of the present invention is M. esculenta WC833 commercially available from Pennsylvania State University (The Pennsylvania State University Mushroom Culture Collection, available from the College of Agriculture Sciences, Department of Plant Pathology and Environmental Microbiology, 117 Buckhout Laboratory, The Pennsylvania State University, University Park, Pa., USA 16802), which demonstrated a heightened ability to grow on hard red winter wheat.
  • Another strain useful for the present invention is a wild-type T. matsutake collected from the Rocky Mountains in the hills just around Nederland, Colo.
  • In one embodiment a filtrate of undefined vegetable (of any type but ideally organic) aqueous extract, such as malt, potato, carrot or a combination thereof is used as growth media. Aqueous potato mixture can be prepared by softening 1-300 g of potato mass in boiling or pressurized water, mashing the potatoes and collecting the filtrate through 1-3 filtrations. Optionally, fruit juice with no added sugars can also be added. In one embodiment, the medium comprises 0.1-10% by weight of malt extract, 0.1-10% by weight of glucose, and 20-80% by weight of water.
  • As a non-limiting example of the media, for example, agar media can be prepared from a media of 15-60 g/L agar with 3-20 g/L organic potato starch powder, 0.3-12 g/L organic carrot powder and 10-200 mL/L organic mango puree in RO filtered water. Any combination of these ingredients may be used. Additional media can include nutritional yeast, brown rice syrup, blackstrap molasses and salts such as diammonium phosphate and ammonium sulfate, all used as is generally done in the art. These solutions are combined and autoclaved. Liquid media is made by the same recipe except agar is omitted.
  • Once prepared the media can be sterilized by any method known in the art. Once the media has cooled post-sterilization it is poured into Petri plates and fungal cultures are propagated from plate to plate in good and clean technical operation as known in the art. Slants for test tubes, liquid flasks and glycerol stocks may be prepared by this method. Petri plates can be inoculated with floating and submerged liquid tissue culture and with myceliated grain.
  • In one embodiment, the fungal component for inoculation into gluten-containing grain can be prepared by submerged liquid tissue culture using the liquid media as defined herein and agitated on a shaker table. In one embodiment, the agitation rate is 50-240 RPM, or 85-95 RPM, and incubated for 1-90 days. In one embodiment, the temperature of incubation is 87-89 ° F.
  • In one embodiment, the fungal component is trained and/or adapted and/or maintained in its ability to efficiently grow on, metabolize or otherwise utilize and/or modify gluten.
  • Therefore, the methods of the invention have as an optional additional step, a method of preparing a trained and/or adapted and/or maintained fungal component comprising a fungal component having an enhanced and/or increased ability to grow on, metabolize or otherwise utilize and/or modify gluten and/or remove gluten from the gluten-containing grain. The methods of the invention further comprise use of any of the trained, adapted and/or maintained fungal component(s) as described herein, in the methods of the instant invention.
  • In one embodiment, methods for preparing the fungal component to inoculate the prepared gluten-containing grain include scaling up a fungal component as defined herein into a large volume bioreactor culture for the inoculation of numerous bags of prepared gluten-containing grain (20-1,000 bags) or for the inoculation of fermenter(s) with large volumes of inoculant (e.g. 10-500 L of inoculant per fermenter). Such a fungal component which is readied for inoculation of the prepared gluten-containing grain is called a “prepared fungal component”.
  • In one embodiment the prepared fungal component is in solid culture. In another embodiment the prepared fungal component is in liquid culture. In another embodiment the prepared fungal component is a mixture of solid and liquid culture. Liquid culture can be accomplished by any means known in the art and includes use of stationary culture and/or a bioreactor. For example, when using a bioreactor to prepare the fungal component, the bioreactor can be prepared by diluting undefined liquid media up to 1000× with filtered water. The jacket of the bioreactor may be steamed in one embodiment to sterilize the media, or alternatively, the media can be sterilized by way of injecting steam into the vessel. In another embodiment both jacket and chamber are steamed. In another embodiment the fermenter is sterilized empty and filled with filter sterilized water and with a sterilized media concentrate, either sterilized in situ and pumped into the fermenter through a sterile line, filter sterilized or sterilized in small batches and pumped into the fermentor. Pasteurization is possible for any or all of these procedures.
  • The media to use in preparation of a fungal component for use to inoculate the prepared gluten-containing grain may be any suitable media known in the art so long as it is human grade (or animal-feed grade depending on the intention of the myceliation) or may be made by the methods disclosed herein. The media may further comprise trace elements and organic substances such as water, nucleic acids, nitrogen content, vitamins and minerals. The media may be diluted up to 1000× with filtered water. Dilution can be 1×, about 2×, about 3×, about 4×, about 5×, about 6×, about 7×, about 8×, about 9×, about 10×, about 15×, about 20×, about 25×, about 30×, about 35×, about 40×, about 45×, about 50×, about 55×, about 60×, about 65×, about 70×, about 80×, about 90×, about 100×, about 150×, about 200×, about 250×, about 300×, about 350×, about 400×, about 450×, about 500×, about 550×, about 600×, about 650×, about 700×, about 750×, about 800×, about 850×, about 900×, about 950× or about 1000×. In some embodiments, the dilution is about 5× to about 100×. For example in a 100 L bioreactor media can be diluted about 10×.
  • In one embodiment, to inoculate the reactor, media may be pumped from another reactor through a sterilized line with an inline pump or by creating positive pressure by sparging air into the reactor with an air compressor system that runs the air through inline 0.2/0.5 μm capsule filters, or equivalent stainless steel cartridge filters, and then through a check valve with a specific cracking pressure, for example, 2-3 psi. Pressure can also be held with a back-pressure regulator. Additionally, pressure can be regulated upstream with a pressure regulator. A slightly pressurized fermenter (1-3 psi) may be opened and have culture poured into it in a clean environment. This procedure is dangerous and should only be executed by one of skill in the art.
  • Methods to inoculate the bioreactor to prepare the fungal component include inoculating the bioreactor with an excised colonized section of Petri plate and/or a sample of myceliated agriculture using sterile procedure, or by pouring a floating or submerged liquid tissue culture into the bioreactor through the nozzle or through a pump.
  • The fungal component optionally may be agitated during culturing by methods known in the art. For example, in a bioreactor the agitation may be accomplished by a combination of sparged air and a motorized paddle which allows both a turbulent environment and shear mechanical force. The inventors, without limitation, have found that the combination is superior to running either method individually, as sparged air creates the most turbulence at the top half of the culture, while affecting the bottom less, which can be kept agitated by a motorized paddle, while the paddle does not have to run at such a high RPM as normally used in the art. More sophisticated setups are known and can be enacted to agitate a bioreactor with liquid culture. Solid state fermenter work has many options known in the art, the most ideal being rotating buckets or agars to evenly and gently agitate grain.
  • Liquid state fermentation agitation and swirling techniques are known in the art and include mechanical shearing using magnetic stir bars, stainless steel impellers, injection of sterile high pressure ambient air, injection at high-pressure of sterile media, and or the use of shaker tables.
  • The fungal component can be grown until ready for inoculation of the prepared gluten-containing grain as determined by one of skill in the art and is most easily monitored with pH. The procedure generally includes a rise in pH. In some embodiments, the fungal component can be grown for 72 hours prior to use in inoculating the gluten-containing grain. Determination of whether the fungal cultures comprising the fungal component are suitable for inoculation of the prepared gluten-containing grain can be determined by one of skill in the art. For example, in one embodiment the fungal culture, when in liquid media, is suitable for inoculation while in log phase, either early or late. Senescing cultures and cultures in secondary phases with lower amounts of mycelia/mL can be used but are not preferred. The prepared fungal component optionally appears well grown through in the media, with visible mycelia growing through every mL visible by microscope and unassisted vision.
  • These methods result in a prepared fungal component for inoculation of prepared gluten-containing grain.
  • The prepared gluten-containing grain is inoculated with the prepared fungal component in a manner so as not to contaminate the culture. The prepared fungal component to be used can be any fungal component as defined in the instant invention. The inoculation of the prepared fungal component onto the prepared gluten-containing grain can be carried out by any method known in the art. This step may be variously referred to as the culturing step, the fermentation step, the incubation step, and/or the myceliation step.
  • The myceliation may take place in a container as described herein. In one embodiment, the myceliation takes place in a 55 gallon drum as described herein. In this embodiment, the 55 gallon drums has a lid containing two ports, and one port can be used as an inoculation port, while the other can be used to sparge in filtered air to the bottom of the culture, and simultaneously serve as a vent. In some embodiments, the inoculation port is a quick disconnect socket, which is attached to a quick disconnect plug at the end of a harvesting line during inoculation. Optionally, prepared gluten-containing grain in a plurality of drums can be myceliated in one cycle via a sterilized manifold connected to bioreactor harvesting line, with the included infrastructure to target any drum in singular or all together at once. In one embodiment a system for volumetrically consistent dispensing of inoculant per culture is used.
  • In one embodiment, the culture may be pneumatically injected into a container comprising the prepared gluten-containing grain. Moisture may optionally be injected into bags to optimize mycelial growth. In another embodiment the prepared gluten-containing grain is inoculated by pouring the culture into the container holding the sterilized gluten-containing grain either manually or through a valve built into the fermenter or bioreactor, the line between the culture containing device and the fermenter/bioreactor being sterilized and cooled, from any variety of liquid tissue culture.
  • In one embodiment, the prepared gluten-containing grain is cooled to a temperature of between 80-100° F. post-sterilization prior to inoculation with the prepared fungal component. Cooling may be accomplished by refrigeration, by running a cooling agent through the fermenter jacket (if using this embodiment) or naturally at room temperature. The step of myceliating the prepared gluten-containing grain can take place for between 1-90 days, and in one embodiment for about 21 days, and at any temperature that enables myelical activity, for example, at 87-89° F. In another embodiment the culture is incubated at room temperature. In another embodiment it is incubated at 65° F. The culture is optionally incubated at 50-90° F.
  • Relative humidity of the solid-state myceliation step is between 20% and 90% and in some embodiments about 75%.
  • The longer the incubation period the greater the production of mycelial dry weight and the greater the gluten hydrolysis in the gluten-containing grain.
  • Determination of when to harvest the myceliated gluten-containing grain may be determined by a number of methods. Harvesting is generally performed with a timing to optimize the taste profile and/or gluten hydrolysis of the myceliated gluten-containing grain according to the taste profile or gluten level desired. For example, the scent profile of the myceliation culture can be used by the trained person to determine when the culture is ready. Determination of the appearance of the culture may also be done by the trained person. Analytical methods of analysis including high performance liquid chromatography (HPLC), PAGE, ELISA etc. may be employed to carry out measurement of gluten or other biomolecules, in order to determine the optimum composition and cultivation conditions and the appropriate time(s) for harvesting the myceliated grain.
  • In some embodiments, the step of culturing or myceliation may also cause reduction and/or removal of gluten as described herein. In some embodiments, determination of the extent of the removal of gluten can be by quantitation, e.g., the chemical composition may be measured by assay methods as are known in the art for gluten measurement.
  • In one embodiment, up to 5% of one or more the proteins comprising gluten is removed; in other embodiments, up to 10%, up to 15%, up to 20%, up to 25%, up to 30%, up to 35%, up to 40%, up to 45%, up to 50%, up to 55%, up to 60%, up to 65%, up to 70%, up to 75%, up to 80%, up to 85%, up to 90%, up to 95%, up to 99%, or up to 99.9% of one or more of gluten is removed in the processes of the instant invention. In one embodiment, gluten is quantitatively removed and is less than about 20 ppm. The invention also relates to myceliated gluten-containing grain having reduced levels of gluten as described herein.
  • In some embodiments, the culturing or myceliation processes of the instant invention provide a myceliated gluten-containing grain with added flavor and/or health promoting components. For example, the myceliated gluten-containing grain may contain exogenously added anti-tumor and immunomodulatory health promoting components such as (1->3)(1->6) β-glucan from the fungi.
  • Fungi are metabolically similar to animals but structurally similar to plants in that they possess a rigid cell wall largely comprising long polysaccharides (β-glucan and chitin) joined by somewhat difficult to digest beta ((β-) linkages and to a smaller extent more easily digestible alpha (α-) linkages in conjunction with membrane-bound proteins. In contrast, plant cell walls (such as gluten-containing grains) are made of cellulose polysaccharides whose (1->4) (β-glycosidic bonds are impossible for humans to digest but are digestible by fungi. Fungi cell walls are primarily composed of (1->3) glycosidic linkages, with (1->6) linked side chains, and therefore they may be broken down by minimal processing using water, heat and mechanical treatment, into smaller, more easily digestible, immunologically-active polysaccharides of variable microparticulate size called and related glycoconjugates. The immune response to β-glucan is dependent upon α- or β-glucan structure, which has primary, secondary, and chiral tertiary structures, explaining the differences in immune response to each fungi's unique α- and/or β-glucan profile. Myceliated gluten-containing grain thus has added health promoting components including the molecules described above. Other health promoting components present in the myceliated gluten-containing grain may be components that have various properties such as immunomodulating, anti-aging, aphrodisiac, anti-tumour, anti-viral, anti-bacterial and/or anti-fungal properties and include compounds such as α- and β-glucans, glycoproteins, proteins, ergosterols, sterols, triterpenes, and fatty acids, glucomannan, riboglucan, sterpuric acid, mannitol, ribitol, nucleic acid content, etc. These molecules are reputed to be immune boosting and modulating, specifically modulating from a Th2 to Th1 immune response.
  • In some embodiments, one fully myceliated, the myceliated gluten-containing grain is optionally dried. Drying can be accomplished by means known in the art for drying gluten-containing grain. For example, myceliated gluten-containing grain may be spread on a dry surface to dry. In one embodiment, the myceliated gluten-containing grain is dried down to an approximately 10-13% moisture content.
  • Optionally, the dried or undried myceliated gluten-containing grain can be pasteurized or sterilized by methods known in the art, which provides for deactivating the fungus. The myceliated gluten-containing grain may then be used as desired. The grain can then be used as per usual and either milled or not. Because more than one strain of filamentous fungus has been discovered to hydrolyze gluten in the solid-state it is likely that more exist.
  • EXAMPLES Example 1
  • Specific and pure strains of fungi obtained from referenced collections were manipulated in sterile environments in 1-10 gal polyproplyene bags, 1 qt-1 gal glass jars or on 9-15 cm Petri plates using undefined, organic fruit and vegetable-based media with 1.5% agar (w/v), in order to monitor and ensure the general vigor and health of strains.
  • Mycelial samples were grown in a gentle, ambient sterile airflow for 0.5-4 weeks, then excised from Petri plates and subsequently used for inoculation into liquid-state myceliation employing a similar undefined fruit and vegetable-based media (but with no agar) using ambient air in 1 qt-1 gal glass jars. Some samples were grown in agitated and some were grown in unagitated cultures in ambient air in stainless steel fermenters.
  • The unagitated liquid state fermentation formed a floating mass of hyphae which exhibited continuous growth at interface of liquid and air. The mycelium of agitated and/or swirling cultures grew very quickly as hyphal spheres which, being hydrated, remained submerged and had the appearance of small diameter gelatinous beads. Hydrated hyphal spheres collapsed upon desiccation, wherein they were used for inoculating petri-plates for strain propagation and quality control.
  • Sphere diameter in liquid-state myceliation was found to be inversely proportional to agitation intensity and volume. Hyphal shear became more efficient at higher agitation and swirling intensity and once sheared hyphae formed new spheres of smallest possible diameter, growing in size until they sheared again. When employed in continuous liquid-state myceliation there existed a constant ratio of sphere diameters, and therefore a constant supply of spheres and hyphal strands adopting spherical morphologies on the order of microns were produced.
  • This example thus demonstrated that mycelia sphere diameter was manipulated for more efficient inoculation with inoculation efficiency being inversely proportional to sphere diameter.
  • Example 2
  • Stationary liquid cultures (growth period of 0.1-4 weeks) formed a floating mass of hyphae, which were gently blended with a sharp, sterile cutting device prior to being used for inoculation. Gentle blending was achieved by mixing or low homogenization in a commercial blender in short bursts at slow speeds. Aliquots of blended liquid-state culture were used to inoculate substrate.
  • Example 3
  • For a large batch liquid-state and solid-state operation pure cultures were grown aerobically and inoculated into large industrial liquid-state and large solid-state commercial processors operated continuously for large-scale myceliation of food products. After cultures of media turned completely white or a representative color thereof for a particular species, and had completely overgrown and commanded the medium and were resistant to gentle mixing, the contents were harvested, removed to plastic bags and refrigerated for quick use at either 4° F. or frozen for long-term storage and subsequent utilization at −20° F.
  • Example 4
  • Agar media was prepared with 15-60 g/L agar and 3-22 g/L organic potato starch powder, 0.3-12 g/L organic carrot powder, and 40 mL/L organic mango puree in RO water. The 1.5 L media was then subjected to a 1.5 hour liquid sterilization cycle and cooled in a clean space for 1-1.5 hours and then poured into 120 Petri plates which cooled for 12 hours.
  • In sterile operation, the Petri plates were inoculated and cultured for 7-14 days. Upon which time they were sterilely propagated into 4 L Erlenmeyer flasks containing 1.5 L of sterilized and cooled media prepared as above but without the mango puree and agar. This culture was shaken at 60 RPM with a 1.5″ swing radius at room temperature for 1-14 days. This culture was used to inoculate organic hard red winter wheat which was prepared as described below.
  • Approximately 0.45 kg samples of organic hard red winter wheat was placed inside 2.2 mm thick polypropylene bags with dimensions of 8″×5″×19″ (width×depth×height) outfitted with a 0.2 μm breather patch. RO filtered water was added at 50% v/m. The bags were subsequently folded around the grain such that the grain was never inverted and the bags were loosely wrapped with EPDM bands.
  • The bags were loaded into an autoclave and subjected to a 1.5 hr liquid sterilization cycle. Once sterilized the bags were cooled in a clean space for 12 hours. Each bag was then inoculated with 170 mL of a submerged liquid tissue culture of M. esculenta which had been cultured for 8 days and then sealed with a bag sealer.
  • The bags myceliated in a clean space for 21 days, upon which time there was resplendent growth of mycelial hyphae throughout the wheat. The bags' content were dried indoors for three days on parchment paper in a laminar air flow. At this point, duplicate samples of myceliated and autoclaved grain were sent to a third-party laboratory to detect the gluten and glutenin fractions of gluten using an ELISA method (Elisa Technologies, Gainesville, Fla., Aller-Tek® Gluten ELISA test kit). The autoclaved control samples were stored at −20 ° C. for the duration of the myceliation.
  • The third-party report concluded an average gluten content of 30 ppm while the control had a level too high to quantitate (the upper limit of quantitation was 80 ppm). The estimated gluten content of the control based on the total protein content and the typical gluten precursor fraction of such wheat is 135,000-160,000 ppm, indicating a greater than 99.99% reduction in gluten content. Once rehydrated, the myceliated gluten-containing grain was essentially aductile and did not knead.
  • Tasters found that the wheat had a pleasant flavor and M. esculenta imbued the grain with a honeysuckle taste.
  • It was found that there was increased crude nitrogen upon completion of the myceliation. The increased protein content was demonstrated as compared to the identically hydrated and autoclaved non-myceliated grain. This finding was unexpected, because in one embodiment instead of a slightly imperfect mass balance between substrate and mycelial nitrogen, the myceliated gluten-containing grain showed a statistically significant increase in total nitrogen content of the culture by 17%. These strains typically have fruit-bodies with high protein content.
  • Example 5
  • Eight 1.023 kg samples of hard red winter wheat with an initial moisture content of 10.3% was ultimately hydrated to 55% with 767 mL of RO water added pre-sterilization and 250 mL inoculant. The mass occupied 25% of a 12 L polypropylene bag with 0.2 μm breather patch. Four bags were inoculated with M. esculenta and four with T. matsutake grown in a media comprising 20 g/L organic potato starch powder and 8 g/L organic carrot powder and were cultured for 12 days. For each strain two bags were set at room temperature and two at 65° F. Visible myceliation was noticed after 3-5 days for every culture and by day 21 the bags were fully colonized. Samples were sent for gluten ELISAs. The M. esculenta cultures yielded a gluten content of 19.67 ppm while the T. matsutake cultures were at 50 ppm.
  • Example 6
  • The grain is dispensed into a food grade pressure vessel capable of agitation, and is sterilized. This is the most efficient way to sterilize and cool large volumes of grain. The grain is inoculated in situ, with controlled humidity, sterile air supply and temperature. Once myceliation is deemed complete, a process that will take anywhere from 1-22 days if done properly (e.g. the culture is at peak vigor of the log phase, the grain serendipitously provides a desirable carbon/nitrogen ratio, contamination is kept at bay, humidity and temperature are controlled for, etc.), and even shorter with some strains. The grain can then be pasteurized in this pressure vessel by methods known in the art, if so desired, and even dried therein. Both of these steps can be accomplished by other methods known in the art. The grain is considered ‘gluten-free’ by many of the world's regulatory authorities. Methods known in the art can easily produce a ‘gluten-free’ flour according to the FDA, and some embodiments of the invention will produce a grain with gluten content less than 20 ppm.

Claims (21)

What is claimed is:
1. A method for preparation of a gluten-containing grain having reduced levels of gluten, comprising:
a) providing a prepared gluten-containing grain comprising the steps of:
i. providing a gluten-containing grain;
ii. sterilizing or pasteurizing the gluten-containing grain to provide prepared gluten-containing grain;
b) providing a prepared fungal component;
c) inoculating the prepared gluten-containing grain with the prepared fungal component; and
d) incubating the prepared gluten-containing grain and prepared fungal component to hydrolyze gluten, resulting in the gluten-containing grain having reduced levels of gluten, wherein the gluten comprises prolamin, glutelin or prolamin/glutelin aggregate.
2. The method of claim 1, wherein the method further comprises drying the gluten-containing grain from step (d).
3. The method of claim 1, wherein the method comprises pasteurizing the gluten-containing grain from step (d).
4. The method of claim 1, wherein the method of step a) further comprises hydrating the gluten-containing grain.
5. The method of claim 1, wherein the gluten-containing grain having lowered levels of gluten has had more than 90% of gluten hydrolyzed compared to the prepared gluten-containing grain.
6. The method of claim 1, wherein the gluten-containing grain having lowered levels of gluten has had more than 95% of gluten hydrolyzed, compared to the prepared gluten-containing grain.
7. The method of claim 1, wherein the gluten-containing grain having lowered levels of gluten has had more than 99.99% of gluten hydrolyzed, compared to the prepared gluten-containing grain.
8. The method of claim 1, wherein the prepared fungal component is a submerged fungal liquid tissue culture.
9. The method of claim 1, wherein the incubating step comprises culturing to induce myceliation.
10. The method of claim 9, wherein the culturing step is performed for between one and forty-two days.
11. The method of claim 1, wherein the submerged fungal liquid tissue culture is grown in a human food-grade media.
12. The method of claim 1, wherein the submerged fungal liquid tissue culture is grown in an animal feed-grade media
13. The method of claim 1, wherein gluten is selected from the group consisting of prolamin, glutelin and an aggregate of prolamin and glutelin.
14. The method of claim 1, wherein gluten content is measured by measuring prolamin, glutenin, or prolamin/glutelin aggregate.
15. The method of claim 1, wherein the prepared fungal component is selected from the group consisting of Hericium erinaceus, Pleurotus ostreatus, Pleurotus eryngii, Pleurotus citrinopileatus, Pleurotus djamor, Trametes versicolor, Lentinula edodes, Armillariella mellea Tricholoma matsutake, Flammulina velutipes, Volvariella volvacea, Agaricus campestris, Agaricus blazei, Grifola frondosa, Pholiota nameko, Agrocybe cylindracea, Boletus ornatipes, Boletus edulis, Ganoderma lucidum, Ganoderma applanatum, Hypsizygus marmoreus, Morchella angusticeps, Morchella esculenta, Morchella hortensis, Phellinus linteus, Auricularia auricula, Tremella fuciformis, Inonotus obliquus, Fomes fomentarius, Laetiporus sulfureus, Bridgeoporus nobillismus, Stropharia rugosoannulata, Clitocybe spp., Cordyceps sinensis, Cordyceps militaris, and Polyporus umbellatus, and combinations thereof.
16. The method of claim 14, wherein the prepared fungal component is M. esculenta.
17. The method of claim 14, wherein the prepared fungal component is T. matsutake.
18. The method of claim 1, wherein the prepared fungal component is prepared by a method comprising screening a number of strains of fungi and selecting a strain having an enhanced ability to tolerate, grow on, metabolize or utilize gluten.
19. The method of claim 1, wherein the prepared fungal component is prepared by a method comprising maintaining a strain of fungi on an undefined media comprising organic gluten and an energy source.
20. The method of claim 1, wherein the gluten-containing grain is selected from the group consisting of Triticum spp., Hordeum spp., Secale spp., Zea spp., Sorghum spp., and Avena spp.
21. A gluten-containing grain having lowered levels of gluten prepared by the method of claim 1.
US17/233,656 2015-02-26 2021-04-19 Methods for lowering gluten content using fungal cultures Abandoned US20210274818A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US17/233,656 US20210274818A1 (en) 2015-02-26 2021-04-19 Methods for lowering gluten content using fungal cultures

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562121483P 2015-02-26 2015-02-26
PCT/US2016/019929 WO2016138476A1 (en) 2015-02-26 2016-02-26 Methods for lowering gluten content using fungal cultures
US201715551894A 2017-08-17 2017-08-17
US17/233,656 US20210274818A1 (en) 2015-02-26 2021-04-19 Methods for lowering gluten content using fungal cultures

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2016/019929 Continuation WO2016138476A1 (en) 2015-02-26 2016-02-26 Methods for lowering gluten content using fungal cultures
US15/551,894 Continuation US10980257B2 (en) 2015-02-26 2016-02-26 Methods for lowering gluten content using fungal cultures

Publications (1)

Publication Number Publication Date
US20210274818A1 true US20210274818A1 (en) 2021-09-09

Family

ID=56789367

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/551,894 Active US10980257B2 (en) 2015-02-26 2016-02-26 Methods for lowering gluten content using fungal cultures
US17/233,656 Abandoned US20210274818A1 (en) 2015-02-26 2021-04-19 Methods for lowering gluten content using fungal cultures

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US15/551,894 Active US10980257B2 (en) 2015-02-26 2016-02-26 Methods for lowering gluten content using fungal cultures

Country Status (2)

Country Link
US (2) US10980257B2 (en)
WO (1) WO2016138476A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11343978B2 (en) 2016-04-14 2022-05-31 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US11950607B2 (en) 2016-04-14 2024-04-09 Mycotechnology, Inc. Myceliated vegetable protein and food compositions comprising same
US11992025B2 (en) 2014-03-15 2024-05-28 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113519814B (en) 2014-08-26 2024-04-02 麦可科技有限公司 Composition containing mycelium liquid tissue culture supernatant and food and application thereof
US9572364B2 (en) 2014-08-26 2017-02-21 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
US10709157B2 (en) 2014-08-26 2020-07-14 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
US10980257B2 (en) 2015-02-26 2021-04-20 Myco Technology, Inc. Methods for lowering gluten content using fungal cultures
BR112018070148A2 (en) 2016-04-14 2019-05-07 Mycotechnology Inc methods for the production and use of high protein mycelial food compositions
WO2020061502A1 (en) 2018-09-20 2020-03-26 The Better Meat Company Enhanced aerobic fermentation methods for producing edible fungal mycelium blended meats and meat analogue compositions
EP3870147A4 (en) * 2018-10-24 2022-08-31 Prothera Biologics, Inc. Inter-alpha inhibitor proteins and methods of use thereof

Family Cites Families (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7322C (en) 1919-08-18 1922-07-15 The Floyd W Robison Co PROCESS FOR TREATING COFFEE BEANS.
US1822227A (en) 1927-12-21 1931-09-08 Louise B P Lendrich Process of improving coffee-beans
US2451567A (en) 1946-09-10 1948-10-19 Mense Elmer H Le Process for preparing starch hydrolyzing enzyme with aspergillus
US2505811A (en) 1947-12-06 1950-05-02 George M Wilcs Essence of mushroom and its preparation
US2693665A (en) 1948-01-23 1954-11-09 Humfeld Harry Production of mushroom mycelium by submerged culture in a liquid medium
US2693664A (en) 1949-08-20 1954-11-09 Szuecs Joseph Method of enhancing mushroom mycelium flavor
US2761246A (en) 1953-05-19 1956-09-04 Szuecs Joseph Mushroom culture
US2928210A (en) 1958-01-13 1960-03-15 Anheuser Busch Fermentation process for producing edible mushroom mycelium
US3086320A (en) 1961-08-08 1963-04-23 Producers Creamery Company Process and composition for growing mushroom mycelium submerged fermentation
JPS5622520B1 (en) 1970-02-24 1981-05-26
US3810997A (en) 1971-10-07 1974-05-14 Kraftco Corp Treatment of soybeans with yeast
US3749584A (en) 1972-03-28 1973-07-31 Us Agriculture Decaffeination of beverages
JPS5320025B2 (en) 1973-08-10 1978-06-24
US4071973A (en) 1975-05-13 1978-02-07 Chiyokichi Iizuka Method of artificially growing edible fungi
GB2059243B (en) 1979-09-24 1983-06-08 Anvar Process for the fermentation of cocoa beans
JPS58149697A (en) 1982-02-27 1983-09-06 Dainippon Ink & Chem Inc Preparation of beta-1,3-glycosyl stevioside
DE3239219A1 (en) 1982-10-22 1984-04-26 Coffex AG, 8201 Schaffhausen METHOD FOR REDUCING THE CHLOROIC ACID CONTENT OF RAW COFFEE
JPS61219340A (en) 1985-03-27 1986-09-29 Lotte Co Ltd Fermentation treatment of cacao nib
JPH0679547B2 (en) 1985-10-16 1994-10-12 大日本インキ化学工業株式会社 Stevia sweetener and method for producing the same
US4891220A (en) 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
JPH04126037A (en) 1990-09-14 1992-04-27 Lotte Co Ltd Improvement in flavor of cacao nib and processed product thereof by enzymatic treatment
US5228396A (en) * 1992-04-20 1993-07-20 Gunter Pfaff Apparatus for culturing plant materials as foods
DE4341316A1 (en) 1993-12-03 1995-06-08 Lehmann Maschf F B Sterilisation, pre-drying, and drying of raw cocoa beans and cocoa nibs
US5934012A (en) 1994-11-23 1999-08-10 Hps Biotechnologies, Inc. Process for production of mushroom inoculum
DK0946106T3 (en) 1996-12-23 2002-09-16 Dsm Nv Process for preparing a protein hydrolyzate
CA2328966C (en) 1998-04-17 2007-09-25 Alltech, Inc. Compositions for removal of mycotoxins from feed
JPH11346657A (en) 1998-06-04 1999-12-21 Natl Food Res Inst Sterilization of cacao bean
CN1155694C (en) 1999-04-23 2004-06-30 筑波生物系统有限会社 Method for culturing a basidiomycetous fungus in a liquid culture medium
US6383799B1 (en) 1999-10-15 2002-05-07 Medmyco Ltd. Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
US6372462B2 (en) 1999-10-15 2002-04-16 Medmyco Ltd. Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
US6277396B1 (en) 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance
US6558943B1 (en) 2000-09-05 2003-05-06 Sun Ten Pharmaceutical Co., Ltd. Method for propagating fungi using solid state fermentation
US8765138B2 (en) 2004-01-06 2014-07-01 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
US20110008384A1 (en) 2004-01-06 2011-01-13 Paul Edward Stamets Antiviral activity from medicinal mushrooms
US6660290B1 (en) 2000-10-04 2003-12-09 Myco Pesticides Llc Mycopesticides
US20140105928A1 (en) 2004-01-06 2014-04-17 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
US6569475B2 (en) 2000-10-06 2003-05-27 Jae-Mahn Song Process for mycelial culture using grain
JP2002191354A (en) 2000-10-06 2002-07-09 Kabaiotekku Co Ltd Method for producing mushroom mycelium
DE10053051C2 (en) 2000-10-13 2002-10-31 Coty Bv Cosmetic preparation with plant extracts
US6476003B1 (en) 2000-11-06 2002-11-05 Immusonic, Inc. Method for preparing small particle size glucan in a dry material
US6956120B2 (en) 2000-11-09 2005-10-18 Yasushi Onaka β-1.3-1.6 glucan (Aureobasidium medium)
AU2002244133A1 (en) 2001-02-20 2002-09-04 Paul Stamets Delivery systems for mycotechnologies, mycofiltration and mycoremediation
AT413540B (en) 2001-12-20 2006-03-15 Erber Ag MICRO-ORGANISM, WHICH EXTRACT OCHRATOXINS AND OCHRATOXINS AND ZEARALENONE, AND METHOD AND USE THEREFOR
CA2490452C (en) 2002-06-25 2013-05-28 Asahi Denka Co., Ltd. .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan
US6723356B2 (en) 2002-07-03 2004-04-20 Ariake Japan Co. High quality fermented bouillon, and method for production thereof
KR100454766B1 (en) 2002-08-20 2004-11-03 주식회사 엔비텍 Biotreatment for milk-processing wastewater using mushroom's mycelia
DE60307766T2 (en) 2002-12-10 2007-10-11 Ajinomoto Co., Inc. Spices and process for its preparation
JP2005027540A (en) 2003-07-09 2005-02-03 Ikse:Kk Agaricus blazei drink
US20050031761A1 (en) 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
CN1870899B (en) 2003-09-25 2010-09-29 三得利控股株式会社 Method of processing green coffee beans
DE602005015547D1 (en) 2004-01-30 2009-09-03 Kao Corp COFFEE DRINK COMPOSITION
JP4587442B2 (en) 2004-02-12 2010-11-24 株式会社クレハ Novel antihyperlipidemic agent and food
US7652204B2 (en) 2004-06-08 2010-01-26 Ndsu Research Foundation Breeding of fusarium resistant tetraploid durum wheat
US7407795B2 (en) 2004-07-15 2008-08-05 John Holliday Method for growing Cordyceps sinensis on a substrate and novel method for hybridizing different strains of Cordyceps sinensis
US7514085B2 (en) 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
WO2006063219A2 (en) 2004-12-09 2006-06-15 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
US20110081448A1 (en) 2005-01-05 2011-04-07 Firmenich Sa Process for treating vanilla beans
EP1709969A1 (en) * 2005-04-07 2006-10-11 Praktijkonderzoek Plant en Omgeving B.V. Health promoting dairy and food products containing mushroom glucan produced through fermentation of Grifola frondosa
BRPI0611411A2 (en) 2005-05-25 2010-09-08 Suntory Ltd method of treating green coffee beans under ph regulation
US20060280753A1 (en) 2005-06-11 2006-12-14 Mcneary Peter Composition and Method For Obtaining A Nutritional Food Product Using Solid Substrate Fermentation
WO2007031186A1 (en) 2005-09-12 2007-03-22 Vrije Universiteit Brussel Starter cultures and fermentation method
MY151122A (en) 2005-10-05 2014-04-30 Asahi Breweries Ltd Method of producing filamentous fungus culture product
KR100747787B1 (en) 2006-02-23 2007-08-08 안영환 A method for manufacturing a soybean paste including pine mushroom
FI20065182A0 (en) 2006-03-20 2006-03-20 Elixi Oil Oy Fermented food
US8133527B2 (en) * 2006-06-16 2012-03-13 Kraft Foods Global Brands Llc Production of stabilized whole grain wheat flour and products thereof
WO2008043058A1 (en) 2006-10-05 2008-04-10 Archer-Daniels-Midland Company Method of producing high-brightness cocoa powder and related compositions
US20080187574A1 (en) 2007-02-05 2008-08-07 Holliday John C Mycellated grain and other myceliated agricultural materials to be used as animal food supplement
ES2519466T3 (en) 2007-03-09 2014-11-07 Novozymes A/S Thermostable asparagininases
US9034402B2 (en) 2007-04-16 2015-05-19 Solae, Llc Protein hydrolysate compositions having improved sensory characteristics and physical properties
JP5031508B2 (en) 2007-04-19 2012-09-19 ハウス食品株式会社 Fenugreek seed with reduced bitterness and method for producing the same
EA018424B1 (en) 2007-04-20 2013-07-30 ДСМ АйПи АССЕТС Б.В. Asparaginase enzyme variants and uses thereof
US20080274234A1 (en) 2007-05-01 2008-11-06 Carter Robert Miller Processing cocoa beans and other seeds
US20080296223A1 (en) 2007-05-30 2008-12-04 Bryan Hiromoto Bioremediation methods using fungal compositions
DE102007027825A1 (en) 2007-06-13 2008-12-18 C-Lecta Gmbh Amidohydrolases for the treatment of food or beverages
KR101529892B1 (en) 2007-06-29 2015-06-18 맥네일 뉴트리셔널즈, 엘엘씨 Stevia-containing tabletop sweeteners and methods of producing same
JP5475945B2 (en) 2007-11-20 2014-04-16 花王株式会社 Containerized coffee beverage
US20090220645A1 (en) 2008-02-25 2009-09-03 Luis Federico Martinez Quality Enhancement of Coffee Beans by Acid and Enzyme Treatment
WO2009138418A2 (en) 2008-05-15 2009-11-19 Barry Callebaut Ag Method for processing cocoa beans
US8529981B2 (en) 2008-05-16 2013-09-10 Bioexx Specialty Proteins Ltd. Protein concentrates and isolates, and processes for the production thereof
US8821955B2 (en) 2008-05-16 2014-09-02 Siebte Pmi Verwaltungs Gmbh Protein concentrates and isolates, and processes for the production thereof
US8623445B2 (en) 2008-05-16 2014-01-07 Bio-Extraction Inc. Protein concentrates and isolates, and processes for the production thereof
EP2316278B1 (en) 2008-08-29 2013-04-10 Pharvis R&D Korea Co., Ltd. Method for producing fermented edible plants or edible animal/plants, fermented edible plants or edible animal/plants produced by same, and foods containing same
ES2412266T3 (en) 2008-10-02 2013-07-10 Suntory Beverage & Food Limited Roasted coffee beans and roasted coffee beans storage method
FR2937866B1 (en) 2008-10-30 2010-11-26 Natura Cosmeticos Sa ANTIOXIDANT COMPLEX, COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPLEX AND THE USE OF SAID COMPLEX
JP5576386B2 (en) 2008-11-25 2014-08-20 アモーレパシフィック コーポレイション Method for producing fermented tea using Bacillus sp.
BRPI0916167B1 (en) 2008-11-28 2018-04-10 Olam International Limited Method for removing contaminants from cocoa pits, cocoa liquor and food product
MX2011006024A (en) 2008-12-12 2011-06-21 Givaudan Sa Fermentation process.
IT1392414B1 (en) * 2008-12-23 2012-03-02 Giuliani Spa PROCEDURE OF MICROBIAL BIOTECHNOLOGY FOR THE COMPLETE DEGRADATION OF GLUTEN IN FLOURS.
WO2010095919A1 (en) 2009-02-18 2010-08-26 Universiti Sains Malaysia A solid state fermentation (ssf) system
EP2405765A4 (en) 2009-03-11 2017-03-15 Cargill, Incorporated Process for making a cocoa product
US20100239711A1 (en) 2009-03-23 2010-09-23 Pei-Jung Li Method for manufacturing coffee by solid state fermentation
US9701986B2 (en) 2009-07-29 2017-07-11 Barry Callebaut Ag Microbial composition for the fermentation of cocoa material
JP2011041540A (en) 2009-08-24 2011-03-03 Asahi Breweries Ltd METHOD FOR PRODUCING beta-GLUCANASE AND XYLANASE WITH WASTE FUNGUS BODY AND LIQUID CULTURE MEDIUM
WO2011032244A1 (en) 2009-09-17 2011-03-24 Blazei Brazil Ltda Flours produced from fungus myceliated grain
US20120231114A1 (en) * 2009-09-17 2012-09-13 Blazei Brazil Ltda. Flours produced from fungus myceliated grain
KR20140079248A (en) 2009-09-21 2014-06-26 엔시아 바이오사이언스 인크 Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states
US20120177781A1 (en) 2009-09-29 2012-07-12 Masahiro Hayashi Method for softening beans
AU2010317479B2 (en) 2009-11-11 2014-10-23 Siebte Pmi Verwaltungs Gmbh Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal
US8486675B2 (en) 2009-11-11 2013-07-16 Bioexx Specialty Proteins Ltd. Protein concentrates and isolates, and processes for the production thereof from macroalgae and/or microalgae
US20110189220A1 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
US20110206721A1 (en) 2010-02-19 2011-08-25 Vijaya Nair Fermented soy nutritional supplements including mushroom components
US9353173B2 (en) 2010-03-02 2016-05-31 Renaissance Bioscience Corp. Functional enhancement of microorganisms to minimize production of acrylamide
CN102869772A (en) 2010-04-27 2013-01-09 帝斯曼知识产权资产管理有限公司 Novel asparaginase enzyme
US8728550B2 (en) 2010-05-07 2014-05-20 Menon Renewable Resources, Inc. Animal meal that includes fungal biomass
EP2576761B1 (en) 2010-06-03 2017-02-08 Carmel-Haifa University Economic Corporation Ltd Extracts of cyathus striatus mushrooms, pharmaceutical compositions comprising them and a new cyathus striatus strain
US8227224B2 (en) 2010-06-09 2012-07-24 Ford Global Technologies, Llc Method of making molded part comprising mycelium coupled to mechanical device
MX340937B (en) 2010-07-14 2016-08-01 Nestec Sa Asparaginase from basidiomycetes.
ES2373852B1 (en) 2010-07-29 2012-12-18 Consejo Superrior De Investigaciones Cientificas (Csic) BIOLOGICAL DEGRADATION OF OCRATOXIN A IN ALPHA OCRATOXINE.
JP5574991B2 (en) 2011-01-07 2014-08-20 新潟麦酒株式会社 Medium for truffle cultivation and truffle mycelium
NL2008812C2 (en) 2012-05-14 2013-11-18 Ssipfeed B V ANIMAL FEED MATERIAL AND USE OF THE FEED MATERIAL.
US9068171B2 (en) 2012-09-06 2015-06-30 Mycotechnology, Inc. Method for myceliating coffee
US20190364921A1 (en) 2012-09-06 2019-12-05 Mycotechnology, Inc. Method for manufacturing cordyceps sinensis-myceliated green tea
US9427008B2 (en) 2012-09-06 2016-08-30 Mycotechnology, Inc. Method of myceliation of agricultural substates for producing functional foods and nutraceuticals
US20140170264A1 (en) 2012-09-06 2014-06-19 Mycotechnology, Inc. Improved method for myceliating raw coffee beans including removal of chlorogenic acids
CN102860541B (en) 2012-09-07 2016-01-13 窦桂明 A kind of nothing is had a strong smell, without the preparation method of fishy smell mutton soup
WO2014055035A1 (en) 2012-10-04 2014-04-10 Phyto Pharma Pte Ltd New cordyceps militaris strain cbs 132098 and biologically active fruiting bodies, mycelial biomass and extracts therefrom
BR112015023468B1 (en) 2013-03-15 2021-11-23 Mycotechnology, Inc MICELY PRODUCTS AND METHODS FOR THE PRODUCTION OF MICELY PRODUCTS FROM COCOA AND OTHER AGRICULTURAL SUBSTRATES
US10231469B2 (en) 2014-03-15 2019-03-19 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
US20160120201A9 (en) 2014-03-15 2016-05-05 Mycotechnology, Inc. Myceliated Coffee Products and Methods for Making Myceliated Coffee Products
KR101487724B1 (en) 2014-06-11 2015-02-06 주식회사 알비알 Processed Brown Rice Using Fermented Rice Bran Extract and Preparing Method Thereof
US9572364B2 (en) 2014-08-26 2017-02-21 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
CN113519814B (en) 2014-08-26 2024-04-02 麦可科技有限公司 Composition containing mycelium liquid tissue culture supernatant and food and application thereof
US10709157B2 (en) 2014-08-26 2020-07-14 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
US10980257B2 (en) 2015-02-26 2021-04-20 Myco Technology, Inc. Methods for lowering gluten content using fungal cultures
US10806101B2 (en) 2016-04-14 2020-10-20 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
BR112018070148A2 (en) 2016-04-14 2019-05-07 Mycotechnology Inc methods for the production and use of high protein mycelial food compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992025B2 (en) 2014-03-15 2024-05-28 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
US11343978B2 (en) 2016-04-14 2022-05-31 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US11950607B2 (en) 2016-04-14 2024-04-09 Mycotechnology, Inc. Myceliated vegetable protein and food compositions comprising same

Also Published As

Publication number Publication date
US20180064148A1 (en) 2018-03-08
US10980257B2 (en) 2021-04-20
WO2016138476A1 (en) 2016-09-01

Similar Documents

Publication Publication Date Title
US10980257B2 (en) Methods for lowering gluten content using fungal cultures
US10010103B2 (en) Methods for the production and use of myceliated high protein food compositions
US11343978B2 (en) Methods for the production and use of myceliated high protein food compositions
US6569475B2 (en) Process for mycelial culture using grain
CN105639627A (en) Phellinus igniarius juice health-care food and preparation method thereof
CN101015379B (en) Process for preparing agaricus blazei healht-care liquid
CN101906453B (en) Fermentation process for preparing nisin
KR20110031324A (en) Yeast extract with high glutamic acid content and producing method thereof
JP2024501297A (en) Fungal biomass production
CN104342372B (en) Method for producing yeast autolysate by probiotic fermentation
CN115736087A (en) Method for enhancing nutrition of soybean protein isolate based on solid state fermentation of edible fungi
CN110129163A (en) A method of producing hickory chick yellow rice wine
史敏 et al. Optimum condition of ecologic feed fermentation by Pleurotus ostreatus using soybean curd residue as raw materials
CN106319003A (en) Composite fungus glycopeptide manufacturing technique
KR20140045790A (en) Method for preparing makgeolli using monascus sp. and makgeolli prepared thereby
CN102326763B (en) Method for preparing yeast extract (YE) from Chinese red dates
KR20100056158A (en) The method of cultivation of mushroom mycelium using of the natural nutrient broth and the manufacturing method which can significantly increase the content rate of crop mycelium and the manufacturing method of agricultural products manufactured by using of the method thereof and the agricultural products manufactured by using of the method thereof and food and beverage products manufactured by using of it as a raw material
US20240155983A1 (en) Active Mycelium Compound Extraction Process
CN115944046A (en) Application of armillaria mellea in degrading vomitoxin
WO2023239868A1 (en) Methods for the production of mycelial biomass
TW201444968A (en) Solid-state fermentation method for producing liquid-state culture of mushrooms
JP2001204459A (en) Liquid culture medium for microorganism
CN115044477A (en) Isaria japonica strain and application thereof
CN113679052A (en) Method for preparing food-grade yeast protein peptide through multiple stress environment
CN108179118A (en) One plant degradation alcohol soluble protein aspergillus oryzae and its application

Legal Events

Date Code Title Description
AS Assignment

Owner name: MYCOTECHNOLOGY, INC., COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LANGAN, JAMES PATRICK;KELLY, BROOKS JOHN;DAVIS, HUNTINGTON;AND OTHERS;REEL/FRAME:056401/0767

Effective date: 20180205

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION